Sanjiv Dwarkanath Kaul

Sanjiv Dwarkanath Kaul

Active Director Director DIN 01550413
DIN 01550413 First appointment Jan 2006 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 11 historical roles
Total affiliations 12 Since Jan 2006
Shareholding value •••• Premium profile

About Sanjiv Dwarkanath Kaul

Data last updated:

Sanjiv Dwarkanath Kaul has 20 years in corporate governance. Holds Director and Designated Partner roles. Currently with 1 company, including Intas Biopharmaceuticals Limited and Nuvo Chryscapital Advisors Private Limited. Formerly with 11 companies, such as Ofaafo Advisors Private Limited and Cavinkare Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Chryscapital Advisors Llp at ₹157 Cr (FY 2020).

DIN 01550413
Primary Designation Director
First Appointment 05 Jan 2006
Oldest Company Age 20 yrs
Largest company Chryscapital Advisors Llp · ₹157 Cr (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Feb 20162016₹157 Cr (FY 2020)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ofaafo Advisors Private Limited U65990HR2022PTC103592
Director13 May 20222022–Active
Cavinkare Private Limited U24246TN1990PTC046613
Director21 Oct 20141990₹1,938 Cr (FY 2025)Active
Mankind Pharma Limited L74899DL1991PLC044843
Director24 Apr 20071991₹14,636 Cr (FY 2026)Active
Aragen Life Sciences Limited U74999TG2000PLC035826
Director07 Feb 20162000₹1,870 Cr (FY 2025)Active
Intas Pharmaceuticals Limited U24231GJ1985PLC007866
Nominee Director05 Jan 20061985₹21,241 Cr (FY 2025)Active
Eris Therapeutics Private Limited U24230GJ2009PTC057670
Director29 Aug 20112009–Amalgamated
Saaya Structures Private Limited U45200DL2008PTC180377
Director10 Jul 20082008–Strike Off
Bioquest Solutions Private Limited U85110KA2005PTC035687
Director25 Aug 20062005₹70.73 Cr (FY 2025)Active
Intas Biopharmaceuticals Limited U24230GJ2005PLC047111
Director02 Aug 20112005–Amalgamated
Director21 May 20122012₹21.8 Lakh (FY 2023)Dissolved Under Section 59(8)

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Intas Biopharmaceuticals Limited
Nuvo Chryscapital Advisors Private Limited
Chryscapital Advisors Llp
Ofaafo Advisors Private Limited
Premium access

Shareholding and investment profile for Sanjiv Dwarkanath Kaul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjiv Dwarkanath Kaul

Sanjiv Dwarkanath Kaul has 20 years in corporate governance. Holds Director and Designated Partner roles. Currently with 1 company, including Intas Biopharmaceuticals Limited and Nuvo Chryscapital Advisors Private Limited. Formerly with 11 companies, such as Ofaafo Advisors Private Limited and Cavinkare Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Chryscapital Advisors Llp at ₹157 Cr (FY 2020).

Sanjiv Dwarkanath Kaul is associated with 1 company as Director and Designated Partner, including Chryscapital Advisors Llp (₹157 Cr).

Sanjiv Dwarkanath Kaul has expertise in General Business.

Sanjiv Dwarkanath Kaul has 20 years in corporate governance.

By reported revenue, the largest current company of Sanjiv Dwarkanath Kaul is Chryscapital Advisors Llp, with revenue of ₹157 Cr (FY 2020).

Sanjiv Dwarkanath Kaul currently holds positions at 1 company: Chryscapital Advisors Llp (₹157 Cr).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available